Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||melanoma||not applicable||SGN-CD228A||Preclinical - Cell line xenograft||Actionable||In a preclinical study, SGN-CD228A treatment delayed tumor growth and resulted in complete responses in cell line xenograft models of melanoma (Cancer Res 2019;79(13 Suppl):Abstract nr 2688).||detail...|
|PubMed Id||Reference Title||Details|
|SGN-CD228A: A novel humanized anti-CD228 antibody-drug conjugate for the treatment of solid tumors||Full reference...|